Pancreatic Enzymes (Pancrelipase) for Bloating and Intestinal Gas
A Strong Evidence Multiple large clinical trials consistently show significant benefits.Standard of care for exocrine pancreatic insufficiency. Pancreatic enzyme replacement therapy (25,000-40,000 lipase units/meal) normalizes fat absorption and helps resolve steatorrhea. FDA-approved medications (Creon, Zenpep).
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dpancreatic\u002Denzymes\u0026condition\u003Dbloating\u002Dand\u002Dgas';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
The Bottom Line
Standard of care for exocrine pancreatic insufficiency. Pancreatic enzyme replacement therapy (25,000-40,000 lipase units/meal) normalizes fat absorption and helps resolve steatorrhea. FDA-approved medications (Creon, Zenpep).
Key Study Findings
Randomized Controlled Trial
26 weeks
Open-label
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control …
Dose: None
vs: Usual nutrition care
Outcome: Quality of life (EORTC-QLQ C30 summary score)
Effect: None
None
Population: Adults with pancreatic cancer (borderline/locally advanced/metastatic)
Case Reports
n=1
Open-label
Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review.
Dose: 20 mg once daily
vs: None
Outcome: Drug-induced pancreatitis
Effect: None
None
Population: 28-year-old woman with severe depression
Review
Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer.
Dose: Pancreatic enzyme replacement therapy (PERT)
vs: None
Outcome: EPI symptom management in pancreatic cancer
Effect: None
None
Population: Patients with pancreatic cancer and EPI
Case Reports
An Infected Intrahepatic Pancreatic Pseudocyst and Calcified Pancreas: A Rare Complication of Chronic Pancreatitis.
Dose: None
vs: None
Outcome: pain reduction
Effect: None
None
Population: None
Review
AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert …
Dose: PERT (pancreatic enzyme replacement)
vs: None
Outcome: EPI diagnosis and treatment guidelines
Effect: None
None
Population: Patients with exocrine pancreatic insufficiency
Other
n=35
26.0 weeks
Isolated Amylase Deficiency in Children and Its Clinical Implication.
Dose: None
vs: None
Outcome: Diarrhea outcomes
Effect: None
None
Population: children
Key Statistics
12
Studies
800
Participants
↑
Positive
A
Grade
Referenced Papers
Nutrition journal
2025
Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review.
Case Report
Frontiers in medicine
2025
Pharmacy (Basel, Switzerland)
2024
2 citations
Gastroenterology
2023
87 citations
Cureus
2023
1 citations
Journal of pediatric …
2019
14 citations
Surgery for obesity …
2018
10 citations
The American journal …
2018
9 citations
The Medical journal …
2017
59 citations
The patient
2017
55 citations
Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer.
Systematic Review
Digestive surgery
2017
37 citations
A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Review
The American journal …
2017
25 citations
Revista medica de …
2008
Digestive diseases and …
1999
40 citations
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 25,000-40,000 lipase units per meal
- epiadults:
- 25,000-50,000 lipase units with meals, 10,000-25,000 with snacks
- epipediatric:
- 500-2,500 lipase units/kg/meal (max 10,000 units/kg/day)
Upper limit: 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | 26 weeks | Mixed | -- |
| 20 mg once daily | -- | Negative | 1 |
| Pancreatic enzyme replacement therapy (PERT) | -- | Positive | -- |
| None | -- | Mixed | -- |
| PERT (pancreatic enzyme replacement) | -- | Positive | -- |
| None | 26.0 weeks | Mixed | 35 |
| 16 g | 8.7 weeks | Mixed | -- |
| None | 52.0 weeks | Mixed | 20 |
Best taken: With meals and snacks; take half the dose at the beginning and half during the meal
Safety & Side Effects
Reported Side Effects
- ⚠ Abdominal pain and cramping
- ⚠ Nausea
- ⚠ Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients)
- ⚠ Hyperuricemia (high doses of protease can increase uric acid)
Known Interactions
- ● Calcium carbonate and magnesium hydroxide antacids (may reduce enzyme activity)
- ● Acarbose and miglitol (pancreatic amylase may counteract alpha-glucosidase inhibitors)
- ● Iron supplements (protease may reduce iron absorption)
- ● Proton pump inhibitors (may improve enzyme efficacy by reducing acid denaturation)
Tolerable upper intake: 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Pancreatic Enzymes (Pancrelipase) help with Bloating and Intestinal Gas?
Based on 12 studies with 800 participants, there is strong evidence from multiple clinical trials that Pancreatic Enzymes (Pancrelipase) may support Bloating and Intestinal Gas management. Our evidence grade is A (Strong Evidence).
How much Pancreatic Enzymes (Pancrelipase) should I take for Bloating and Intestinal Gas?
Studies have used various dosages. A commonly studied range is 25,000-40,000 lipase units per meal. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pancreatic Enzymes (Pancrelipase)?
Reported side effects may include Abdominal pain and cramping, Nausea, Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients), Hyperuricemia (high doses of protease can increase uric acid). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pancreatic Enzymes (Pancrelipase) and Bloating and Intestinal Gas?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.
Related Evidence
Other ingredients for Bloating and Intestinal Gas
References
- [1] Emma McShane et al.. Nutr J. 2025. Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal feeding, … doi:10.1186/s12937-025-01113-9 PubMed
- [2] Yangpeng Wu et al.. Front Med (Lausanne). 2025. Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review. doi:10.3389/fmed.2025.1688065 PubMed
- [3] Mary Acelle G Garcia et al.. Pharmacy (Basel). 2024. Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer. doi:10.3390/pharmacy12020047 PubMed
- [4] David C Whitcomb et al.. Gastroenterology. 2023. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. doi:10.1053/j.gastro.2023.07.007 PubMed
- [5] Nabi Nadia et al.. Cureus. 2023. An Infected Intrahepatic Pancreatic Pseudocyst and Calcified Pancreas: A Rare Complication of Chronic Pancreatitis. doi:10.7759/cureus.35384 PubMed
- [6] Puanani Hopson et al.. J Pediatr Gastroenterol Nutr. 2019. Isolated Amylase Deficiency in Children and Its Clinical Implication. doi:10.1097/MPG.0000000000002317 PubMed
- [7] Anabelle Cloutier et al.. Surg Obes Relat Dis. 2018. Long alimentary limb duodenal switch (LADS): a short-term prospective randomized trial. doi:10.1016/j.soard.2017.08.028 PubMed
- [8] Yalda Zolghadri et al.. Am J Pathol. 2018. Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth. doi:10.1016/j.ajpath.2017.11.014 PubMed
- [9] Mehrdad Nikfarjam et al.. Med J Aust. 2017. Diagnosis and management of pancreatic exocrine insufficiency. doi:10.5694/mja16.00851 PubMed
- [10] Colin D Johnson et al.. Patient. 2017. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome … doi:10.1007/s40271-017-0233-0 PubMed
- [11] Jennifer Straatman et al.. Dig Surg. 2017. Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer. doi:10.1159/000454958 PubMed
- [12] Samer Alkaade et al.. Am J Manag Care. 2017. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. PubMed
- [13] Carla Mancilla A et al.. Rev Med Chil. 2008. [Small intestine bacterial overgrowth in patients with chronic pancreatitis]. PubMed
- [14] F Suarez et al.. Dig Dis Sci. 1999. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. doi:10.1023/a:1026675012864 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.